Annual Interest Expense
$6.03 M
-$9.65 M-61.55%
December 31, 2023
Summary
- As of February 8, 2025, AKBA annual interest expense is $6.03 million, with the most recent change of -$9.65 million (-61.55%) on December 31, 2023.
- During the last 3 years, AKBA annual interest expense has fallen by -$2.84 million (-32.00%).
- AKBA annual interest expense is now -69.74% below its all-time high of $19.94 million, reached on December 31, 2021.
Performance
AKBA Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$6.66 M
+$4.51 M+209.96%
September 30, 2024
Summary
- As of February 8, 2025, AKBA quarterly interest expense is $6.66 million, with the most recent change of +$4.51 million (+209.96%) on September 30, 2024.
- Over the past year, AKBA quarterly interest expense has increased by +$4.51 million (+209.96%).
- AKBA quarterly interest expense is now at all-time high.
Performance
AKBA Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$12.73 M
+$5.25 M+70.25%
September 30, 2024
Summary
- As of February 8, 2025, AKBA TTM interest expense is $12.73 million, with the most recent change of +$5.25 million (+70.25%) on September 30, 2024.
- Over the past year, AKBA TTM interest expense has increased by +$5.25 million (+70.25%).
- AKBA TTM interest expense is now -18.88% below its all-time high of $15.69 million, reached on December 31, 2022.
Performance
AKBA TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
AKBA Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -61.5% | +210.0% | +70.3% |
| 3 y3 years | -32.0% | - | - |
| 5 y5 years | - | - | - |
AKBA Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -69.7% | at low | at high | +372.4% | -18.9% | +111.0% |
| 5 y | 5-year | -69.7% | at low | at high | +372.4% | -18.9% | +545.3% |
| alltime | all time | -69.7% | at low | at high | +372.4% | -18.9% | +545.3% |
Akebia Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.66 M(+210.0%) | $12.73 M(+70.2%) |
| Jun 2024 | - | $2.15 M(-14.0%) | $7.47 M(+7.3%) |
| Mar 2024 | - | $2.50 M(+76.2%) | $6.97 M(+15.5%) |
| Dec 2023 | $6.03 M(-61.5%) | $1.42 M(+0.6%) | $6.03 M(-3.5%) |
| Sep 2023 | - | $1.41 M(-14.1%) | $6.25 M(-28.9%) |
| Jun 2023 | - | $1.64 M(+5.2%) | $8.79 M(-27.9%) |
| Mar 2023 | - | $1.56 M(-4.6%) | $12.19 M(-22.3%) |
| Dec 2022 | $15.69 M | $1.64 M(-58.6%) | $15.69 M(+11.6%) |
| Sep 2022 | - | $3.95 M(-21.5%) | $14.05 M(-7.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $5.04 M(-0.5%) | $15.18 M(+0.5%) |
| Mar 2022 | - | $5.06 M(-0.5%) | $15.11 M(+1.7%) |
| Dec 2021 | $19.94 M(+124.7%) | - | - |
| Sep 2021 | - | $5.08 M(+2.5%) | $14.85 M(+23.3%) |
| Jun 2021 | - | $4.96 M(+3.3%) | $12.04 M(+28.3%) |
| Mar 2021 | - | $4.80 M(+111.3%) | $9.39 M(+43.2%) |
| Dec 2020 | $8.87 M | - | - |
| Sep 2020 | - | $2.27 M(-1.5%) | $6.55 M(+53.1%) |
| Jun 2020 | - | $2.31 M(+17.0%) | $4.28 M(+117.0%) |
| Mar 2020 | - | $1.97 M | $1.97 M |
FAQ
- What is Akebia Therapeutics annual interest expense?
- What is the all time high annual interest expense for Akebia Therapeutics?
- What is Akebia Therapeutics annual interest expense year-on-year change?
- What is Akebia Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly interest expense year-on-year change?
- What is Akebia Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Akebia Therapeutics?
- What is Akebia Therapeutics TTM interest expense year-on-year change?
What is Akebia Therapeutics annual interest expense?
The current annual interest expense of AKBA is $6.03 M
What is the all time high annual interest expense for Akebia Therapeutics?
Akebia Therapeutics all-time high annual interest expense is $19.94 M
What is Akebia Therapeutics annual interest expense year-on-year change?
Over the past year, AKBA annual interest expense has changed by -$9.65 M (-61.55%)
What is Akebia Therapeutics quarterly interest expense?
The current quarterly interest expense of AKBA is $6.66 M
What is the all time high quarterly interest expense for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly interest expense is $6.66 M
What is Akebia Therapeutics quarterly interest expense year-on-year change?
Over the past year, AKBA quarterly interest expense has changed by +$4.51 M (+209.96%)
What is Akebia Therapeutics TTM interest expense?
The current TTM interest expense of AKBA is $12.73 M
What is the all time high TTM interest expense for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM interest expense is $15.69 M
What is Akebia Therapeutics TTM interest expense year-on-year change?
Over the past year, AKBA TTM interest expense has changed by +$5.25 M (+70.25%)